CorrlensCorrlens
Correlate

Correlation Analysis

Eli Lilly & Co. vs Verisk Analytics, Inc. Common Stock

LLY vs VRSK

+0.673

Strong positive

When one moves up, the other tends to follow.

LLY logo

Eli Lilly & Co.

LLY

Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.

Market cap 828.2B · 50,000 employees

VRSK logo

Verisk Analytics, Inc. Common Stock

VRSK

Verisk is a leading data, analytics, and technology provider for property-casualty insurers. Verisk traces its history to Insurance Services Office, a nonprofit advisory organization founded in 1971 by US P&C insurers. ISO was formed as an association of insurance companies to assist with a variety of insurance use cases, such as reporting to regulators, defining policies, and determining independent premium rates. As the firm expanded its use cases, it became a for-profit company, renamed Verisk, and went public in 2009. Verisk's single segment (insurance) provides underwriting solutions, including forms, rules, loss costs, and catastrophe modeling. For claims, Verisk's solutions include property repair estimates and antifraud tools. About 83% of Verisk's revenue is US-based.

Market cap 24.2B · 8,000 employees

Apr 9, 2021 — Apr 7, 2026Daily1,254 data pointsStockStockHealthcare

Time Series

Relative Performance

Green: LLYGray: VRSK36 of 1,254 points (sampled)

Who Moves First

VRSK leads LLY by 6 days

VRSK tends to move before LLY.

After testing 13 timing shifts, the strongest relationship was +0.678 (they moved in the same direction).

Do They Crash Together?

Correlation by Market Regime

How these series behave when markets are rising, falling, or diverging. A correlation that holds in drawdowns is very different from one that only works in rallies.

Both Rising

-0.208

16 periods · Return correlation when both series rose

Both Falling

-0.420

6 periods · Return correlation when both series fell

Diverging

-0.564

13 periods · Return correlation when series moved apart

R-Squared

45.3%

Share of variance in one series explained by the other.

Trend Agreement

60.8%

How often both series moved in the same direction period-to-period.

Overlap Quality

1,254

Deep shared window — 1,254 usable pairs.

Significance

p < 0.001

95% CI: [0.641, 0.702]

Scatter

XY Regression

1142004006008001,0001,142159.6160180200220240260280300320327.5Eli Lilly & Co.Verisk Analytics, Inc. Common StockData pointsFit (r = 0.673)

Pipeline

Data quality details

Pipeline Summary

1,254 paired data points survived the daily window.

Raw input

1,254

1,254

Normalized

1,254

1,254

Prepared

1,254

1,254

Aligned

1,254

1,254

Invalid removed

0

A: 0 / B: 0

Duplicates removed

0

A: 0 / B: 0

Alignment drops

0

A: 0 / B: 0

Series A

LLY logo

Eli Lilly & Co.

LLY

Market cap 828.2B · 50,000 employees

Stock · 1,254 raw → 1,254 prepared

Series B

VRSK logo

Verisk Analytics, Inc. Common Stock

VRSK

Market cap 24.2B · 8,000 employees

Stock · 1,254 raw → 1,254 prepared

Sign agreement

100.0%

How often both values share the same sign.

Zero crossings

15

Estimated crossover points between normalized spreads.

Slope

0.1003

Linear regression slope.

Intercept

169.2764

Linear regression intercept.

Related Extremes

Highest and Lowest Correlated

Saved 6 hours ago · ID: stock-lly-vs-stock-vrsk-daily